NM_001289125.3:c.28T>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001289125.3(IFNAR2):​c.28T>G​(p.Phe10Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.335 in 1,606,830 control chromosomes in the GnomAD database, including 95,222 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F10I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.32 ( 8284 hom., cov: 32)
Exomes 𝑓: 0.34 ( 86938 hom. )

Consequence

IFNAR2
NM_001289125.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4O:1

Conservation

PhyloP100: -1.92

Publications

65 publications found
Variant links:
Genes affected
IFNAR2 (HGNC:5433): (interferon alpha and beta receptor subunit 2) The protein encoded by this gene is a type I membrane protein that forms one of the two chains of a receptor for interferons alpha and beta. Binding and activation of the receptor stimulates Janus protein kinases, which in turn phosphorylate several proteins, including STAT1 and STAT2. The protein belongs to the type II cytokine receptor family. Mutations in this gene are associated with Immunodeficiency 45. [provided by RefSeq, Jul 2020]
IFNAR2 Gene-Disease associations (from GenCC):
  • immunodeficiency 45
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=3.302767E-5).
BP6
Variant 21-33241950-T-G is Benign according to our data. Variant chr21-33241950-T-G is described in ClinVar as [Benign]. Clinvar id is 1170800.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.562 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IFNAR2NM_001289125.3 linkc.28T>G p.Phe10Val missense_variant Exon 2 of 9 ENST00000342136.9 NP_001276054.1 P48551-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IFNAR2ENST00000342136.9 linkc.28T>G p.Phe10Val missense_variant Exon 2 of 9 1 NM_001289125.3 ENSP00000343957.5 P48551-1
IFNAR2-IL10RBENST00000433395.7 linkc.28T>G p.Phe10Val missense_variant Exon 2 of 13 5 ENSP00000388223.3 H0Y3Z8

Frequencies

GnomAD3 genomes
AF:
0.317
AC:
48202
AN:
151950
Hom.:
8274
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.198
Gnomad AMI
AF:
0.245
Gnomad AMR
AF:
0.399
Gnomad ASJ
AF:
0.319
Gnomad EAS
AF:
0.581
Gnomad SAS
AF:
0.492
Gnomad FIN
AF:
0.404
Gnomad MID
AF:
0.380
Gnomad NFE
AF:
0.326
Gnomad OTH
AF:
0.311
GnomAD2 exomes
AF:
0.383
AC:
95264
AN:
248934
AF XY:
0.386
show subpopulations
Gnomad AFR exome
AF:
0.190
Gnomad AMR exome
AF:
0.474
Gnomad ASJ exome
AF:
0.322
Gnomad EAS exome
AF:
0.582
Gnomad FIN exome
AF:
0.391
Gnomad NFE exome
AF:
0.331
Gnomad OTH exome
AF:
0.354
GnomAD4 exome
AF:
0.337
AC:
490087
AN:
1454762
Hom.:
86938
Cov.:
31
AF XY:
0.341
AC XY:
247021
AN XY:
723956
show subpopulations
African (AFR)
AF:
0.191
AC:
6346
AN:
33300
American (AMR)
AF:
0.467
AC:
20644
AN:
44252
Ashkenazi Jewish (ASJ)
AF:
0.321
AC:
8366
AN:
26030
East Asian (EAS)
AF:
0.565
AC:
22307
AN:
39460
South Asian (SAS)
AF:
0.470
AC:
40164
AN:
85538
European-Finnish (FIN)
AF:
0.385
AC:
20454
AN:
53190
Middle Eastern (MID)
AF:
0.396
AC:
2276
AN:
5752
European-Non Finnish (NFE)
AF:
0.315
AC:
348576
AN:
1107126
Other (OTH)
AF:
0.349
AC:
20954
AN:
60114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.444
Heterozygous variant carriers
0
14457
28914
43372
57829
72286
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11412
22824
34236
45648
57060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.317
AC:
48244
AN:
152068
Hom.:
8284
Cov.:
32
AF XY:
0.329
AC XY:
24420
AN XY:
74322
show subpopulations
African (AFR)
AF:
0.198
AC:
8238
AN:
41516
American (AMR)
AF:
0.400
AC:
6106
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.319
AC:
1106
AN:
3472
East Asian (EAS)
AF:
0.580
AC:
3003
AN:
5180
South Asian (SAS)
AF:
0.492
AC:
2373
AN:
4824
European-Finnish (FIN)
AF:
0.404
AC:
4252
AN:
10534
Middle Eastern (MID)
AF:
0.371
AC:
109
AN:
294
European-Non Finnish (NFE)
AF:
0.326
AC:
22171
AN:
67954
Other (OTH)
AF:
0.315
AC:
664
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1657
3313
4970
6626
8283
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
494
988
1482
1976
2470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.319
Hom.:
17923
Bravo
AF:
0.311
TwinsUK
AF:
0.315
AC:
1168
ALSPAC
AF:
0.299
AC:
1151
ESP6500AA
AF:
0.188
AC:
828
ESP6500EA
AF:
0.317
AC:
2726
ExAC
AF:
0.378
AC:
45947
Asia WGS
AF:
0.519
AC:
1801
AN:
3478
EpiCase
AF:
0.333
EpiControl
AF:
0.337

ClinVar

Significance: Benign
Submissions summary: Benign:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 69% of patients studied by a panel of primary immunodeficiencies. Number of patients: 66. Only high quality variants are reported. -

Immunodeficiency 45 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mortality risk in patients with severe coronavirus disease (COVID-19) Other:1
May 06, 2022
HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas
Significance:association
Review Status:no assertion criteria provided
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.045
BayesDel_addAF
Benign
-0.84
T
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.0080
DANN
Benign
0.56
DEOGEN2
Benign
0.10
.;.;T;.;T
Eigen
Benign
-2.2
Eigen_PC
Benign
-2.2
FATHMM_MKL
Benign
0.0024
N
LIST_S2
Benign
0.15
.;T;.;T;T
MetaRNN
Benign
0.000033
T;T;T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
-1.3
N;N;N;N;.
PhyloP100
-1.9
PrimateAI
Benign
0.26
T
PROVEAN
Benign
1.6
N;N;N;N;N
REVEL
Benign
0.0050
Sift
Benign
0.77
T;T;T;T;T
Sift4G
Benign
0.62
T;T;T;T;T
Polyphen
0.0
B;B;B;B;.
Vest4
0.046
MPC
0.046
ClinPred
0.0044
T
GERP RS
-7.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.052
gMVP
0.35
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1051393; hg19: chr21-34614255; COSMIC: COSV59747499; COSMIC: COSV59747499; API